The September 2021 issue of Drug Development & Delivery takes a deep dive into injectables that are either currently in development or recently introduced to the market. This year’s report features our VP of Technical Solutions, Michael Denzer, as he highlights Kymanox’s ability to provide end-to-end solutions to accelerate device development and delivery.